Loading company
Intercure Ltd.
INCR · Nasdaq · ·
$5.21-1.0%Sep 25 close
- 1M
- -9.9%
- 6M
- +37.8%
- 1Y
- -36.5%
- 5Y
- -85.0%
INCR · Nasdaq · ·
$5.21-1.0%Sep 25 close
From the company’s own 6-K filing.
(dba Canndoc) InterCure (dba Canndoc) (NASDAQ: INCR) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated “seed-to-sale” model to lead the fastest growing cannabis global market outside of North America.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K Intercure Ltd. filed on October 8, 2025 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Intercure Ltd. has no earnings call transcript available.